Brief Communication Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy

To identify proteins expressed abnormally in facioscapulohumeral muscular dystrophy (FSHD), we extracted soluble proteins from deltoid muscle biopsies from unaffected control and FSHD patients and analyzed them using two-dimensional electrophoresis, mass spectrometry and immunoblotting. Muscles from patients with FSHD showed large increases over controls in a single soluble, 34 kDa protein (pI=5.08) identified by mass spectrometry and immunoblotting as mu-crystallin (CRYM). Soluble fractions of biopsies of several other myopathies and muscular dystrophies showed no appreciable increases in mu-crystallin. Mu-crystallin has thyroid hormone and NADPH binding activity and so may influence differentiation and oxidative stress responses, reported to be altered in FSHD. It is also linked to retinal and inner ear defects, common in FSHD, suggesting that its up-regulation may play a specific and important role in pathogenesis of FSHD. © 2007 Published by Elsevier Inc.

[1]  G. W. Padberg,et al.  Facioscapulohumeral muscular dystrophy , 2007, Current opinion in neurology.

[2]  R. Tawil,et al.  Facioscapulohumeral muscular dystrophy , 2006, Muscle & nerve.

[3]  A. Oshima,et al.  CRYM mutations cause deafness through thyroid hormone binding properties in the fibrocytes of the cochlea , 2006, Journal of Medical Genetics.

[4]  B. Shneiderman,et al.  Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. , 2006, Brain : a journal of neurology.

[5]  Michael R. Green,et al.  Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1 , 2006, Nature.

[6]  K. Flanigan,et al.  Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy , 2006, Annals of neurology.

[7]  F. Ono,et al.  The FASEB Journal express article 10.1096/fj.04-3525fje. Published online August 12, 2005. , 2022 .

[8]  C. Bisbal,et al.  Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle , 2005, Journal of Molecular Medicine.

[9]  J. Lawrence,et al.  The 4q subtelomere harboring the FSHD locus is specifically anchored with peripheral heterochromatin unlike most human telomeres , 2004, The Journal of cell biology.

[10]  U. Bengtsson,et al.  Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease? , 2004, Human molecular genetics.

[11]  S. Winokur,et al.  Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress , 2003, Neuromuscular Disorders.

[12]  G. V. Ommen,et al.  Facioscapulohumeral muscular dystrophy is uniquely associated with one of the two variants of the 4q subtelomere , 2002, Nature Genetics.

[13]  H. Ding,et al.  Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb element. , 1999, Gene.

[14]  R. Griggs,et al.  Facioscapulohumeral dystrophy: A distinct regional myopathy with a novel molecular pathogenesis , 1998, Annals of neurology.

[15]  J. Francon,et al.  Purification, molecular cloning, and functional expression of the human nicodinamide-adenine dinucleotide phosphate-regulated thyroid hormone-binding protein. , 1997, Molecular endocrinology.

[16]  M. Downes,et al.  Regulation of vertebrate muscle differentiation by thyroid hormone: The role of the myoD gene family , 1995, BioEssays : news and reviews in molecular, cellular and developmental biology.

[17]  K. Mathews,et al.  The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: Implications for a role of chromatin structure in the pathogenesis of the disease , 1994, Chromosome Research.

[18]  G. Wistow,et al.  mu-crystallin is a mammalian homologue of Agrobacterium ornithine cyclodeaminase and is expressed in human retina. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  J. Klose,et al.  Large-gel 2-D electrophoresis. , 1999, Methods in molecular biology.

[20]  J. Klose,et al.  Fractionated extraction of total tissue proteins from mouse and human for 2-D electrophoresis. , 1999, Methods in molecular biology.

[21]  J. J. Grote,et al.  On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy , 1995, Muscle & nerve. Supplement.